Abstract
Few groups of aggressive non-Hodgkin's lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well.
| Original language | English (US) |
|---|---|
| Article number | omab114 |
| Pages (from-to) | 447-449 |
| Number of pages | 3 |
| Journal | Oxford Medical Case Reports |
| Volume | 2021 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Nov 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Case report of primary CD20 negative diffuse large B-cell lymphoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver